Oral Bacterium from Gum Disease Found to Accelerate Breast Cancer Growth
A groundbreaking new study has uncovered a significant connection between oral health and breast cancer progression, revealing how a common bacterium associated with gum disease can enter the bloodstream and dramatically accelerate tumor growth. Researchers from the John Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy discovered that this oral microbe settles in breast tissue, causing DNA damage and making cancer cells more aggressive and resistant to therapy.
Pathogen's Journey from Mouth to Breast Tissue
The study demonstrates that the bacterium, Fusobacterium nucleatum, can travel from the oral cavity through the bloodstream and establish itself in breast tissue. Once there, it initiates a cascade of harmful biological processes. The research team, led by Dr. Dipali Sharma and first author Dr. Sheetal Parida, used both mouse models and human breast cancer cells to trace this pathogen's journey and its devastating effects.
"The key takeaway is that this oral microbe can reside in breast tissue and that there is a connection between this pathogen and breast cancer," explained Dr. Sharma. "Our study was inspired by numerous smaller investigations that had already suggested a link between periodontal disease and breast cancer in thousands of patients. We wanted to dig deeper and uncover the underlying mechanisms."
DNA Damage and Increased Tumor Aggressiveness
When introduced directly into breast ducts, the bacterium caused noncancerous changes accompanied by inflammation and significant DNA damage. More alarmingly, when it entered the bloodstream, it substantially boosted the growth and spread of existing tumors. The research uncovered a critical biological process showing that exposure to F. nucleatum damages cellular DNA and activates error-prone repair systems.
One such repair mechanism introduces mutations when rapidly reconnecting broken DNA strands. Even short exposure to the bacterium increases levels of a protein called PKcs, which is directly linked to cancer cell movement and chemotherapy resistance. Cells lining the breast ducts and breast cancer cells carrying BRCA1 mutations were found to be particularly vulnerable to these effects.
Implications for High-Risk Individuals and Future Research
The study's findings suggest that maintaining good oral health could be relevant to breast cancer risk, particularly for genetically susceptible individuals. "Our findings reveal a link between oral microbes and breast cancer risk and progression, especially in those with genetic predispositions," Dr. Sharma emphasized. "Nothing happens in isolation. Multiple risk factors converge, with F. nucleatum acting as an environmental factor that may cooperate with inherited BRCA1 mutations to promote breast cancer and increase tumor aggressiveness."
While this research provides crucial insights into the connection between oral pathogens and breast cancer, the authors note that further investigation is necessary to understand how these findings translate to patient care. The study opens new avenues for considering oral health as part of comprehensive cancer prevention strategies, particularly for individuals with known genetic risk factors.
